AION Labs is a first-of-its kind venture studio comprised of eight global pharma, tech and innovation leaders. Our mission is to create and adopt groundbreaking AI technologies that revolutionize drug discovery and development, improving health and patient outcomes for global populations. We bring together brilliant scientist-founders from around the world, possessing decades of accumulated knowledge, expertise and data, to tackle the most pressing pharmaceutical R&D challenges. By combining our partners' vast knowledge with a new multidisciplinary approach, alongside the agility and innovation unique to Israel's startup ecosystem, we create new companies advancing the future of healthcare. Our unique venture creation model bridges the gap between academic research in AI and critical R&D needs in developing new medications for the benefit of patients.